BPC-157: A Peptide with Remarkable Healing Potential In addition to the study discussed above, BPC-157 has been subject to numerous studies, and demonstrated promising therapeutic effects in different contexts, such as cellular aging, heart disturbances, spinal cord injuries, and major vessel occlusion disturbances
Mullins RJ, Mustapic M, Chia CW, Carlson O, Gulyani S, Tran J, et al
Mr Mfazo Hove Featured in Newsweek: GLP-1 Medications and Vision Loss Posted Medically Reviewed by: Mr Mfazo Hove, Consultant Ophthalmic Surgeon Author: Chris Dunnington Published: July 16, 2026 Last Updated: July 16, 2026 Mr Mfazo Hove, Consultant Ophthalmic Surgeon and Medical Director of Blue Fin Vision, has been invited by Newsweek to comment on new international research linking GLP-1 medications to a rare optic nerve condition that can cause sudden vision loss
In OZEMPIC: Risks, Benefits, and Natural Alternatives to GLP-1 Weight-Loss Drugs, Dr
doi: 10.1016/j.diabres.2021.108737